Press Releases

 

June 2010: Essen BioScience and Nycomed announce ion channel collaboration
Press Release

 

May 2010: Essen BioScience Launches 96-Well Cell Migration Assays
Press Release

 

April 2010: Essen BioScience announces name change and US Headquarters move.

Press Release

 

March 2010: Essen Instruments signs collaboration agreement with Origene Technologies Inc. for the development of ion-channel cell lines.

Press Release

 

Jan 2010: Essen Instruments and Research Instruments PTE Ltd. Of Singapore sign an international distribution agreement whereby Research Instruments has exclusive distribution rights to Essen's IncuCyte^TM technology in Singapore, Malaysia and Thailand.

 

Jan 2010: Essen Instruments achieves sixth consecutive year of organically-driven revenue growth.

 

 

July 2009: Essen Instruments launches a European-based contract screening center based in Welwyn Garden City.

Press Release

 

June 2009: Essen Instruments and IUL GmbH of Konigswinter, Germany sign an international distribution agreement whereby IUL has exclusive distribution rights to Essen's IncuCyte^TM technology in Germany.

 

April 2009: Essen Instruments and TCS CellWorks (Birmingham, UK) enter into a strategic collaboration to develop and distribute live-cell angiogenesis kits.

Press Release

 

 

Nov 2008: Essen Instruments begins beta-release of the IncuCyte^FLR. This instrument adds fluorescence capability to the live-cell imaging product line enabling kinetic read-outs for assays including cellular proliferation and co-culture angiogenesis.

 

Oct 2008: Vince Groppi, Ph.D, V.P. and CSO of Essen Instruments delivers podium presentation at the 2008 Society of Biomolecular Sciences (SBS) Cell-based Assays: Innovations in Reagents, Technologies & Screening Symposium in King of Prussia, PA. Vince’s talk was entitled: HT Organ Pharmacological Assays for Drug Discovery.

 

Sept 2008: Vince Groppi, Ph.D, V.P. and CSO of Essen Instruments delivers plenary podium presentation at the 2008 Assays & Cellular Targets (ACT) Conference in San Diego. The talk was entitled: Long-term Live-Cell Imaging of Angiogenesis in Co-Culture.

 

June 2008: Essen Instruments and Tekon Technologies Ltd. of Hong Kong sign an international distribution agreement whereby Tekon has exclusive distribution rights to Essen’s IncuCyte^TM and Pipeline^TM products in China and Taiwan.

 

June 2008: Essen Instruments and Millennium Science Pty Ltd. of Australia sign an international distribution agreement whereby Millennium has exclusive distribution rights to Essen’s IncuCyte^TM and Pipeline^TM products in Australia and New Zealand.

 

June 2008: Essen Instruments hires David Rock, Ph.D. as Director of Advanced Biotechnology. Dave will add his 25 years experience in pre-clinical drug discovery to support new bio-technology development programs at Essen, including building applications for Essen’s contract services business unit.

 

April 2008: Essen Instruments releases HD phase imaging mode. HD Imaging is a type of phase imaging invented by Essen which is relatively insensitive to fluid-meniscus artifacts and thus allows for high contrast images in 96 and 384-well microplates.

 

Jan 2008: Essen hires Peter Djali, Ph.D. as European Sales Manager. Pete is responsible for European sales for Essen's IncuCyte^TM and Pipeline^TM products in the UK and Europe.

 

 

Sept 2007: Essen Instruments hires Vince Groppi, Ph.D. as Vice-President, Chief Scientific Officer. Vince will use his 25 years experience in pharmaceutical research to lead Essen’s biotechnology group responsible for both contract research via Essen’s Discovery Services business unit as well as instrumentation applications development.

 

March 2007: Essen Instruments establishes a wholly-owned UK subsidiary, Essen Instruments Ltd. to establish direct sales and distribution of Essen product in the UK and Europe.